Chemed Corp
NYSE:CHE

Watchlist Manager
Chemed Corp Logo
Chemed Corp
NYSE:CHE
Watchlist
Price: 550.115 USD 0.08%
Market Cap: 8B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+26%
Revenue
Forecast
+7%
Operating Income
Forecast
+10%
Net Income
Forecast
+12%

Wall Street
Price Targets

CHE Price Targets Summary
Chemed Corp

Wall Street analysts forecast CHE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CHE is 690.88 USD with a low forecast of 656.5 USD and a high forecast of 743.4 USD.

CHE Lowest Forecast
Wall Street Target
656.5 USD
19% Upside
CHE Average Forecast
Wall Street Target
690.88 USD
26% Upside
CHE Highest Forecast
Wall Street Target
743.4 USD
35% Upside
Lowest
Price Target
656.5 USD
19% Upside
Average
Price Target
690.88 USD
26% Upside
Highest
Price Target
743.4 USD
35% Upside
Chemed Corp Competitors:
Price Targets
CCRN
Cross Country Healthcare Inc
29% Upside
A
9860
Adicon Holdings Ltd
46% Upside
600763
Topchoice Medical Co Inc
11% Upside
E
1846
Euroeyes International Eye Clinic Ltd
97% Upside
CCRN
Cross Country Healthcare Inc
29% Upside
A
9860
Adicon Holdings Ltd
46% Upside
600763
Topchoice Medical Co Inc
11% Upside
E
1846
Euroeyes International Eye Clinic Ltd
97% Upside
LALPATHLAB
Dr. Lal PathLabs Ltd
8% Upside
PRDA
Prodia Widyahusada Tbk PT
5% Upside
1951
Jinxin Fertility Group Ltd
27% Upside
DGX
Quest Diagnostics Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Chemed Corp

For the last 8 years the compound annual growth rate for Chemed Corp's revenue is 6%. The projected CAGR for the next 3 years is 7%.

6%
Past Growth
7%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Chemed Corp

For the last 8 years the compound annual growth rate for Chemed Corp's operating income is 10%. The projected CAGR for the next 3 years is 10%.

10%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Chemed Corp

For the last 8 years the compound annual growth rate for Chemed Corp's net income is 14%. The projected CAGR for the next 3 years is 12%.

14%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

See Also

Summary
CHE intrinsic value, competitors valuation, and company profile.
DCF Valuation
CHE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CHE stock valuation using valuation multiples.
Wall Street Estimates
CHE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CHE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CHE's stock price target?
Price Target
690.88 USD

According to Wall Street analysts, the average 1-year price target for CHE is 690.88 USD with a low forecast of 656.5 USD and a high forecast of 743.4 USD.

What is Chemed Corp's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Chemed Corp's revenue is 6%. The projected CAGR for the next 3 years is 7%.

What is Chemed Corp's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Chemed Corp's operating income is 10%. The projected CAGR for the next 3 years is 10%.

What is Chemed Corp's Net Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Chemed Corp's net income is 14%. The projected CAGR for the next 3 years is 12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 262,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.